Beijing Aosaikang Pharmaceutical Valuation

Q: What is the Fair Price of 002755 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

002755 (CN¥13.23) is trading below our estimate of [[fair value]] (CN¥31.81)

Is 002755 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002755 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002755 (CN¥13.23) is trading below our estimate of fair value (CN¥31.81)

Significantly Below Fair Value: 002755 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002755?

Key metric: As 002755 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 002755. This is calculated by dividing 002755's market cap by their current earnings.
What is 002755's PE Ratio?
PE Ratio	75.3x
Earnings	CN¥163.14m
Market Cap	CN¥12.28b

002755 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.1x
Enterprise Value/EBITDA	93.9x
PEG Ratio	3.5x

Price to Earnings Ratio vs Peers

How does 002755's PE Ratio compare to its peers?

The above table shows the PE ratio for 002755 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	32.9x
603567 Heilongjiang ZBD Pharmaceutical	16.7x	n/a	CN¥10.9b
300026 Tianjin Chase Sun PharmaceuticalLtd	71.6x	34.4%	CN¥11.9b
002332 Zhejiang Xianju PharmaceuticalLtd	19.2x	22.0%	CN¥11.9b
688553 Sichuan Huiyu Pharmaceutical	24.3x	n/a	CN¥6.8b
002755 Beijing Aosaikang Pharmaceutical	75.3x	21.7%	CN¥12.3b

Price-To-Earnings vs Peers: 002755 is expensive based on its Price-To-Earnings Ratio (75.3x) compared to the peer average (32.9x).

Price to Earnings Ratio vs Industry

How does 002755's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 002755 is expensive based on its Price-To-Earnings Ratio (75.3x) compared to the CN Pharmaceuticals industry average (29.6x).

Price to Earnings Ratio vs Fair Ratio

What is 002755's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002755 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	75.3x
Fair PE Ratio	27.8x

Price-To-Earnings vs Fair Ratio: 002755 is expensive based on its Price-To-Earnings Ratio (75.3x) compared to the estimated Fair Price-To-Earnings Ratio (27.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Jiangsu Kanion PharmaceuticalLtd

CN¥8.1b

Researches and develops, produces, and sells Chinese medicines.

600557

CN¥14.31

-1.4%

-24.4%

Hunan Jiudian Pharmaceutical

CN¥11.5b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

300705

CN¥23.30

1.8%

13.1%

Dong-E-E-JiaoLtd

CN¥36.4b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

423

CN¥56.59

-2.4%

12.8%